Karyopharm therapeutics inc

Major-Pharmaceuticals

KPTI


85 Wells Avenue
Newton , MA 02459

Executive/
Director

Price

  • Last Close
  • $ 0.78
    $ -0.02 -2.5 %
    Jan 3, 2025
  • 52-Week High/Low
  • $1.66 - $0.68
  • YTD
  • 18.2%

  • Trading Volume
  • 10,530
  • Market Cap Full
  • $ 89.3M
  • Shares Outstanding
  • 114.5M
    Oct 27, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -32.7% 36.6% 39.8% -37.7% -5% -31.1% 17.5% 14.4% 72.3% 18.2%
Q2 -24.8% -29.5% 35.5% 11% 4% -1.3% -40.3% -54% -39.7% -
Q3 45% 21.3% -5.7% 64.9% 8% -43.6% 21.1% -25.1% -21.4% -
Q4 -3.4% -19.9% -44.7% 98.1% 4% 10.5% -37.7% -29.1% -24.2% -
J F M A M J J A S O N D
2025 18.2% - - - - - - - - - - -
2024 -13.2% 54.5% 28.5% -24.8% -13% -1.6% 2.9% -21.4% - - - -21.9%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -65%-29%2%-2%101%-19%-58%-47%-75%-24%18%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.75 0.71 -0.78 -1.09 -0.78 -0.77 -0.53 -0.30
Q2 0.84 0.64 -0.6 -0.71 -0.63 -0.71 -0.62 -0.29
Q3 0.69 0.65 -0.79 -0.67 -0.73 -0.69 -0.45 -0.30
Q4 0.65 0.80 -0.97 -0.75 -0.58 0.52 -0.42 -
A 2.9 2.8 -3.1 -3.2 -2.7 -1.7 -2 -0.89

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 60.9 65.5 74.6 79.2 113.3
Jun 49.8 60.9 73.1 75.1 79.4 114
Sep 60.6 61.9 73.5 75.5 79.8 114.4
Dec 60.7 62.8 73.6 75.5 81.2 114.5

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.3 0.8 1 - -
Fixed Asset Turnover 78.5 9.6 4 6.8 4.3
Total Asset Turnover 0.4 0.7 0.4 0.1 0.1
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -6.2 -3.8 -7.2 -17.2 90
Equity multiplier -0.1 -0.3 0.5 0.1 -